Brief: G1 Therapeutics Q4 basic EPS USD -0.21
28/02/2024 11:33
Feb 28 (Reuters) - G1 Therapeutics Q4 net income USD -10.878 million. * Q4 pretax profit USD -9.976 million vs. IBES estimate USD -15.2 million * Q4 basic EPS USD -0.21 * Q4 operating expenses USD 23.802 million * Q4 product sales USD 13.922 million
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify